Advanced search
Publication Cover
Cancer Investigation Volume 41, 2023 - Issue 8
Submit an article Journal homepage
712
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Tumor Differentiation as a Prognostic Marker in Clinically Staged T1bN0 Esophageal Adenocarcinoma

Ofer Margalita Department of Oncology, Sheba Medical Center, Tel-Hashomer, Ramat-Gan, Israel;b Faculty of Medicine, Tel-Aviv University, Ramat-Aviv, Tel-Aviv, IsraelCorrespondence[email protected]
View further author information
,
Einat Shacham-Shmuelia Department of Oncology, Sheba Medical Center, Tel-Hashomer, Ramat-Gan, Israel;b Faculty of Medicine, Tel-Aviv University, Ramat-Aviv, Tel-Aviv, IsraelView further author information
,
Gal Straussa Department of Oncology, Sheba Medical Center, Tel-Hashomer, Ramat-Gan, Israel;b Faculty of Medicine, Tel-Aviv University, Ramat-Aviv, Tel-Aviv, IsraelView further author information
,
Yu-Xiao Yangc Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA;d Department of Medicine, Division of Gastroenterology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USAView further author information
,
Yaacov R. Lawrencea Department of Oncology, Sheba Medical Center, Tel-Hashomer, Ramat-Gan, Israel;b Faculty of Medicine, Tel-Aviv University, Ramat-Aviv, Tel-Aviv, Israel;e Department of Radiation Oncology, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, Pennsylvania, USAView further author information
,
Alon Ben Nunf Faculty of Medicine, Ben-Gurion University, Be’er-Sheva, Israel;g Assuta Medical Center, Tel-Aviv, IsraelView further author information
,
Idan Levyh Department of Gastroenterology, Sheba Medical Center, Tel-Hashomer, Ramat-Gan, IsraelView further author information
,
Kim A. Reissi Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, USAView further author information
,
Talia Golana Department of Oncology, Sheba Medical Center, Tel-Hashomer, Ramat-Gan, Israel;b Faculty of Medicine, Tel-Aviv University, Ramat-Aviv, Tel-Aviv, IsraelView further author information
,
Naama Halperna Department of Oncology, Sheba Medical Center, Tel-Hashomer, Ramat-Gan, Israel;b Faculty of Medicine, Tel-Aviv University, Ramat-Aviv, Tel-Aviv, IsraelView further author information
,
Dan Aderkaa Department of Oncology, Sheba Medical Center, Tel-Hashomer, Ramat-Gan, Israel;b Faculty of Medicine, Tel-Aviv University, Ramat-Aviv, Tel-Aviv, IsraelView further author information
,
Bruce Giantonioj Department of Medicine, Division of Hematology and Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USAView further author information
,
Ronac Mamtanic Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA;f Faculty of Medicine, Ben-Gurion University, Be’er-Sheva, IsraelView further author information
&
Ben Boursia Department of Oncology, Sheba Medical Center, Tel-Hashomer, Ramat-Gan, Israel;b Faculty of Medicine, Tel-Aviv University, Ramat-Aviv, Tel-Aviv, Israel;c Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USAView further author information
 show all
Pages 734-738 | Received 29 Mar 2023, Accepted 02 Sep 2023, Published online: 18 Sep 2023

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.